REGROW Act to do reappearing act?

October 30, 2016 Paul Knoepfler 1

One of the biggest stem cell news stories of 2016 has been the REGROW Act, a bill intended to accelerate investigational stem cell and regenerative medicine therapies to patients by lessening FDA oversight, but in the last couple months REGROW […]


Our bodies, not our cells?

October 24, 2016 Paul Knoepfler 15

Do we own our cells? Do we have some intrinsic right to them once they are outside our bodies? One of the arguments I hear most often from physicians at stem cell clinics and some clinic patients is that patients have an […]